Pfizer to halt biosimilar production activities in China

Reuters · 03/17/2021 03:58
Pfizer to halt biosimilar production activities in China

- Pfizer Inc PFE.N has decided to halt its entire manufacturing activities of biosimilars in China, a Pfizer representative told Reuters in a written response.


(Reporting by Roxanne Liu and Ryan Woo
Editing by Shri Navaratnam)

((hongkong.newsroom@thomsonreuters.com; (8610)6627-1277; Reuters Messaging: roxanne.liu@thomsonreuters.com))